Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Feldman

Showing results (471-480 of 753) with videos related to

Pageof 76
Sort By:
Journal of Cardiovascular Pharmacology|October 10, 2023
Evaluation and Management of Pericarditis in Rheumatic DiseasesYumeko Kawano, Maria A Pabón, Candace H Feldman, et al.
Alzheimer Disease and Associated Disorders|June 30, 2009
Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezilRoy W Jones, Elias Schwam, David Wilkinson, et al.
Pediatrics|December 1, 1980
Effect of dietary protein and carbohydrate on theophylline metabolism in childrenC H Feldman, V E Hutchinson, C E Pippenger, et al.
Journal of General Internal Medicine|October 15, 2010
Improving blood pressure control: results of home-based post-acute care interventionsLiliana E Pezzin, Penny H Feldman, Jennifer M Mongoven, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 1999
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendationsC J Patterson, S Gauthier, H Bergman, et al.
Plos One|July 20, 2018
Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findingsAlyssa Wohlfahrt, Anarosa Campos, Maura D Iversen, et al.
Arthritis Care & Research|January 28, 2015
Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus NephritisJose A Gómez-Puerta, Candace H Feldman, Graciela S Alarcón, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2025
Implications of practice effects for the design of Alzheimer clinical trialsJasmin A Duehring, Diane M Jacobs, Michael L Thomas, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Serum p97 levels as an aid to identifying Alzheimer's diseaseH. Feldman, R. Gabathuler, M. Kennard, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 1999
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on DementiaC J Patterson, S Gauthier, H Bergman, et al.
Pageof 76

Showing results (471-480 of 753) with videos related to

Sort By:
Pageof 76
Journal of Cardiovascular Pharmacology|October 10, 2023
Evaluation and Management of Pericarditis in Rheumatic DiseasesYumeko Kawano, Maria A Pabón, Candace H Feldman, et al.
Alzheimer Disease and Associated Disorders|June 30, 2009
Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezilRoy W Jones, Elias Schwam, David Wilkinson, et al.
Pediatrics|December 1, 1980
Effect of dietary protein and carbohydrate on theophylline metabolism in childrenC H Feldman, V E Hutchinson, C E Pippenger, et al.
Journal of General Internal Medicine|October 15, 2010
Improving blood pressure control: results of home-based post-acute care interventionsLiliana E Pezzin, Penny H Feldman, Jennifer M Mongoven, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 1999
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendationsC J Patterson, S Gauthier, H Bergman, et al.
Plos One|July 20, 2018
Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findingsAlyssa Wohlfahrt, Anarosa Campos, Maura D Iversen, et al.
Arthritis Care & Research|January 28, 2015
Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus NephritisJose A Gómez-Puerta, Candace H Feldman, Graciela S Alarcón, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2025
Implications of practice effects for the design of Alzheimer clinical trialsJasmin A Duehring, Diane M Jacobs, Michael L Thomas, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Serum p97 levels as an aid to identifying Alzheimer's diseaseH. Feldman, R. Gabathuler, M. Kennard, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 1999
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on DementiaC J Patterson, S Gauthier, H Bergman, et al.
Pageof 76